Our partnership Buchanan has supported BioPharma Credit with financial communications consulting through a developed engagement programme. This has increased the visibility and awareness of the new fund and its investment case among investment media audiences and the sell side community. We continue to be a strategic partner to the fund on its growth journey.
Growth story A year on from listing on the London Stock Exchange, BioPharma Credit had already raised $1.1bn to fund its unique life sciences debt investment mandate, much of which has been raised and deployed in high profile transactions.